Medical Director/Exec. Director, Gastrointestinal (GI) Immunology (Translational Medicine)

Ulcerative colitis and Crohn's disease, along with other gastrointestinal ailments, represent a diverse array of conditions impacting millions globally. These afflictions have significant unmet medical needs and often lead to a diminished quality of life. Novartis stands at the forefront of pharmaceutical innovation in immunology, leveraging advanced scientific research to develop transformative treatments that enhance patients' lives worldwide. We are seeking a Medical Director or Executive Director of Gastrointestinal (GI) Immunology in Translational Medicine Immunology. Join us in this endeavor!

You will provide medical and scientific leadership and expertise in a role that significantly impacts the drug development pipeline.

• Drive success of early global programs, develop and implement strategies to achieve Transition Decision Point (TDP)
• Drive success of late global programs by developing and implementing strategies, which lead to clinical pharmacology and profiling packages that meet regulatory requirements and support differentiated and competitive drug labeling.
• Support Translational Research in developing new indications, endpoints and biomarkers, using in vitro, in vivo, or in silico methods.
• Provide scientific expert assessments and support for in-licensing opportunities, including due diligences.